Clinical Trial Update: Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study [Phase 3]

View source ↗

Summary

Completed Phase 3 cohort study evaluating pentamidine prophylaxis to prevent relapses of visceral leishmaniasis in HIV-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Visceral Leishmaniasis

Drugs mentioned

• Pentamidine (pentamidine)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Visceral Leishmaniosis, HIV-infection/Aids | Phase 3 | Status: COMPLETED | Results posted: 2019-02-15